Delivery Order W81K0224D0009-W81K0224F0135
Award Date
9/29/24
Potential Completion Date
9/28/25
Potential Value
$41K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Revvity Omics Inc.
Ultimate Awardee
Revvity Inc.
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South Korea
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for newborn screening testing services provided by Revvity Omics Inc., doing business as Perkinelmer Genetics, to the Defense Health Agency (DHA) for the Brian D. Allgood Army Community Hospital (BDAACH) in South Korea. The contract is a firm fixed price delivery order under a larger indefinite delivery, indefinite quantity (IDIQ) contract awarded to Perkinelmer Genetics in 2019 by the DHA to provide newborn screening for Army medical facilities in Korea. The...
The Department of the Army Medical Command awarded a $34,329.12 firm fixed price delivery order to Perkinelmer Genetics, Inc. for newborn screening testing services in support of the Brian D. Allgood Army Community Hospital and 121st Combat Support Hospital in Korea. The testing will be conducted under an Other Transaction for Prototype III agreement and is to be completed by September 28, 2023. Perkinelmer Genetics, Inc. is a subsidiary of Revvity Inc., which operates in the medical imaging...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Revvity Omics Inc., doing business as Perkinelmer Genetics, for newborn screening testing services. The contract has a ceiling value of $848,688.00 and a period of performance ending on September 30, 2029. Perkinelmer Genetics, a subsidiary of Revvity Inc., is a for-profit organization that specializes in medical imaging and genetic testing services, particularly newborn screening programs to detect...
This firm fixed-price purchase order contract was awarded by the Department of the Army Medical Command to Revvity Omics Inc., doing business as Perkinelmer Genetics, for comprehensive newborn screening services. The contract has a potential value of $375,186.00 and a completion date of September 30, 2016. Perkinelmer Genetics, a for-profit subsidiary of Revvity Inc., specializes in medical imaging and genetic testing services. This contract supports the military healthcare system by providing...
The Department of the Army Medical Command awarded a $45,092.88 firm fixed price delivery order to Perkinelmer Genetics, Inc. of Pittsburgh, Pennsylvania for newborn screening testing services in support of Brian D. Allgood Army Community Hospital and the 121st Combat Support Hospital in Korea. As the prime contractor, Perkinelmer Genetics will provide newborn screening to be performed at its laboratory in Pittsburgh on samples collected at the Army medical treatment facilities. The testing...
This delivery order against the Defense Health Agency's Newborn Screening Testing Services contract awards Perkinelmer Genetics, Inc. $8,918.84 to provide newborn screening testing services for the Brian D. Allgood Army Community Hospital in South Korea from June 1, 2023 through September 28, 2023. As the prime contractor, Perkinelmer Genetics will perform the testing at its own facilities, with oversight from the Defense Health Agency. The contract has no set-aside designation and utilizes a...
The Department of the Army Medical Command awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to Perkinelmer Genetics, Inc., a for-profit organization, to provide newborn screening tests. The contract has a potential value of $143,440.00 and a performance period ending on September 30, 2018. Perkinelmer Genetics, a subsidiary of Revvity Inc., specializes in newborn and genetic screening services, and has provided similar testing support to military hospitals and treatment...
This federal contract award to Revvity Omics Inc., doing business as Perkinelmer Genetics, is for $197,264 to provide newborn genetic screening services to the U.S. Air Force's Air Mobility Command. The firm fixed price purchase order has an ultimate completion date of August 9, 2028. Perkinelmer Genetics is a subsidiary of Revvity Inc., a for-profit organization specializing in medical imaging and genetic testing. This contract is not set aside. Perkinelmer Genetics has held numerous prior...
This is a firm fixed-price contract awarded by the U.S. Army Medical Command (MEDCOM) to Revvity Omics Inc., doing business as Perkinelmer Genetics, for $99,600.00. The contract is for newborn screening services, which involve testing infants for conditions such as galactosemia, hypothyroidism, sickle cell disease, and cystic fibrosis. Perkinelmer Genetics, a subsidiary of Revvity Inc., is the prime contractor and will perform the screening tests at its own laboratories. This contract does not...
This is a firm fixed price purchase order contract awarded by the Defense Health Agency to Revvity Omics Inc., doing business as Perkinelmer Genetics, for newborn screening services. The contract has a ceiling value of $371,000.00 and a period of performance from October 1, 2021 through September 30, 2024. Perkinelmer Genetics will provide screening of newborns for inherited metabolic disorders and other conditions, as recommended by the American College of Medical Genetics, for military...